• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Paul S. Bernstein, MD, PhD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
50 4.7 out of 5 Patient Rating

Languages Spoken: English

Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Director of Clinical Research and Associate Director of Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

Clinical Locations

John A. Moran Eye Center

801-581-2352

65 N Mario Capecchi
Salt Lake City, UT  84132
Map

Midvalley Health Center

801-585-3937

243 East 6100 South
Murray, UT  84107
Map

Specialties

  • Diabetic Retinopathy
  • Ophthalmology
  • Retinal Diseases

Board Certification and Academic Information

Academic Departments Ophthalmology/Visual Sciences - Professor
Neurobiology - Adjunct Professor
Pharmacology and Toxicology - Adjunct Professor
Board Certification American Board of Ophthalmology
National Board of Medical Examiners

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.7/ 5

Care provider's explanation of condition/problem

4.7/ 5

Care provider's effort to include me in decisions

4.6/ 5

Wait time at clinic

4.2/ 5

Care provider's concern for questions & worries

4.6/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient November 28, 2022
John A Moran Eye Center

5 out of 5 stars

High regard for Dr Bernstein and associates

UofU Patient November 25, 2022
Midvalley Health Center

5 out of 5 stars

I send my family members to Dr Bernstein. I trust him completely.

UofU Patient November 24, 2022
John A Moran Eye Center

5 out of 5 stars

Dr Penrod is great. He listens and works with me for good outcomes

UofU Patient November 22, 2022
John A Moran Eye Center

5 out of 5 stars

I ALWAYS A FOLDER MADE UP TO GIVE TO FRIENDS WHEN THEY REQUEST SPECISL MEDICAL SERVICES!

UofU Patient November 19, 2022
John A Moran Eye Center

3 out of 5 stars

Dr. B is a man of few words.

UofU Patient November 14, 2022
John A Moran Eye Center

5 out of 5 stars

Great visit with excellent attention to all my concerns and joys. Received excellent post op news about my healing!

UofU Patient November 09, 2022
John A Moran Eye Center

5 out of 5 stars

He took the time to explain the option for a medical procedure and was ver patient in answering my list of questions.

UofU Patient November 09, 2022
John A Moran Eye Center

5 out of 5 stars

I'm very grateful for Dr. Bernstein! His skill is masterful and caring and provides me with trust and hope!

UofU Patient October 17, 2022
MORAN EYE CENTER

5 out of 5 stars

Always the best care

UofU Patient October 13, 2022
MORAN EYE CENTER

5 out of 5 stars

Dr bernstien is very very good

UofU Patient October 11, 2022
MORAN EYE CENTER

5 out of 5 stars

I like that I was able to see the images of my exams.

UofU Patient October 10, 2022
MORAN EYE CENTER

5 out of 5 stars

Dr Bernstein and other physician explain everything before any need for questions. Excellent understanding of my other neurological issues and concerns that might impact my surgery.

UofU Patient October 09, 2022
MORAN EYE CENTER

5 out of 5 stars

They are always excellent in every way possible. I was quite late this time and they all stayed to take care of my treatment. They went above and beyond for me. They were all extremely gracious and caring

UofU Patient October 08, 2022
MORAN EYE CENTER

5 out of 5 stars

I always have High Praise for my Doctors and Staff

UofU Patient October 07, 2022
MORAN EYE CENTER

5 out of 5 stars

Very food. That is why I have been going to the Moran for many years.

UofU Patient September 15, 2022
MORAN EYE CENTER

5 out of 5 stars

The best!

UofU Patient September 03, 2022
MORAN EYE CENTER

5 out of 5 stars

Excellent

UofU Patient September 02, 2022
MORAN EYE CENTER

3 out of 5 stars

As a medical professional, I can tell that Dr. Bernstein is obviously very knowledgeable and I trust him, but it seemed like all he wanted to do was get out of the room. I had many questions and concerns, considering I'm thirty and possibly going blind, and it felt like I was a burden on him. I understand he's busy, and if he can treat/cure me, then great. But I would also appreciate a provider that would answer my questions, calm my anxiety, and take the time to ensure I was comfortable with the treatment plan.

UofU Patient September 01, 2022
MORAN EYE CENTER

5 out of 5 stars

I always tell people how awesome the Moran is!!

UofU Patient August 28, 2022
MORAN EYE CENTER

3 out of 5 stars

I honestly do not know ! Think that provider might develop more skill in listening to patient's questions about testing.

UofU Patient August 13, 2022
MORAN EYE CENTER

5 out of 5 stars

Excellent care always

UofU Patient August 11, 2022
MORAN EYE CENTER

5 out of 5 stars

Dr Bernstein and those assisting him were professional and focused on my recovery progress from surgery.

UofU Patient August 11, 2022
MORAN EYE CENTER

4 out of 5 stars

Dr. Bernstein seemed a little rushed on this day like he was overbooked or had too much going on. My questions got answered, but very quickly like he needed to get to the next patient.

UofU Patient July 18, 2022
MORAN EYE CENTER

5 out of 5 stars

I would recommend Dr. Bernstein but not the gentleman that gave me the first shot.

UofU Patient July 14, 2022
MORAN EYE CENTER

5 out of 5 stars

At all visits and during all appointments we were treated very respectively

UofU Patient July 13, 2022
MORAN EYE CENTER

5 out of 5 stars

This was a shorter follow up visit, but Dr. Bernstein was still very thorough.

UofU Patient July 11, 2022
MORAN EYE CENTER

5 out of 5 stars

Dr. Bernstein is always wonderful. I saw a medical student as well and he was very good and professional.

UofU Patient July 11, 2022
MORAN EYE CENTER

5 out of 5 stars

I was taking very well of and they were very caring that they showed kindness and empathy was over and beyond what they needed to do

UofU Patient July 02, 2022
MORAN EYE CENTER

5 out of 5 stars

This was one of my follow-up visits, a quick check and I was on my way home.

Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Director of Clinical Research and Associate Director of Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

Academic Locations

Board Certification and Academic Information

Academic Departments Ophthalmology/Visual Sciences - Professor
Neurobiology - Adjunct Professor
Pharmacology and Toxicology - Adjunct Professor
Board Certification American Board of Ophthalmology
National Board of Medical Examiners

Education History

Fellowship Massachusetts Eye and Ear Infirmary
Vitreoretinal Surgery
Fellow, 1995
Residency UCLA Medical Center, Jules Stein Eye Institute
Ophthalmology
Resident, 1993
Postdoctoral Fellowship UCLA Medical Center, Jules Stein Eye Institute
Cell Biology
Postdoctoral Fellow, 1990
Internship New England Deaconess Hospital
Internal Medicine
Intern, 1989
Doctoral Training Harvard University
Pharmacology
Ph.D., 1988
Professional Medical Harvard Medical School/MIT - Division of Health Sciences & Technology
Medicine
M.D., 1988
Undergraduate Harvard University
Chemistry, summa cum laude
A.B., 1981

Selected Publications - Journal Articles

Journal Article

  1. Cheng V, Rallabandi R, Gorusupudi A, Lucas S, Rognon G, Bernstein PS, Rainier JD, Conboy JC (2022). Influence of very-long-chain polyunsaturated fatty acids on membrane structure and dynamics. Biophys J, 121(14), 2730-2741.
  2. Rai BB, Morley MG, Bernstein PS, Maddess T (2022). Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study. BMC Ophthalmol, 22(1), 298.
  3. Bernstein PS (2022). Nourishing Better Vision: The ARVO 2021 Mildred Weisenfeld Award Lecture. Invest Ophthalmol Vis Sci, 63(3), 13.
  4. Li B, Vachali P, Chang FY, Gorusupudi A, Arunkumar R, Shi L, Rognon GT, Frederick JM, Bernstein PS (2021). HDL is the primary transporter for carotenoids from liver to retinal pigment epithelium in transgenic ApoA-I-/-/Bco2-/- mice. Arch Biochem Biophys, 716, 109111.
  5. Takayanagi Y, Obana A, Muto S, Asaoka R, Tanito M, Ermakov IV, Bernstein PS, Gellermann W (2021). Relationships between Skin Carotenoid Levels and Metabolic Syndrome. Antioxidants (Basel), 11(1).
  6. Obana A, Gohto Y, Asaoka R, Gellermann W, Bernstein PS (2021). Lutein and Zeaxanthin Distribution in the Healthy Macula and Its Association with Various Demographic Factors Examined in Pseudophakic Eyes. Antioxidants (Basel), 10(12).
  7. Iannaccone A, Brewer CC, Cheng P, Duncan JL, Maguire MG, Audo I, Ayala AR, Bernstein PS, Bidelman GM, Cheetham JK, Doty RL, Durham TA, Hufnagel RB, Myers MH, Stingl K, Zein WM, Foundation Fighting Blindness Consortium Investigator Group (2021). Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A). Am J Med Genet A, 185, 3717-3727.
  8. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2021). LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel). Retina, 41(7), 1416-1427.
  9. Wade A, Rallabandi R, Lucas S, Oberg C, Gorusupudi A, Bernstein PS, Rainier JD (2021). The synthesis of the very long chain polyunsaturated fatty acid (VLC-PUFA) 32:6 n-3. Org Biomol Chem, 19(25), 5563-5566.
  10. Arunkumar R, Gorusupudi A, Li B, Blount JD, Nwagbo U, Kim HJ, Sparrow JR, Bernstein PS (2021). Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-/- double knockout mice. Exp Eye Res, 209, 108680.
  11. Goerdt L, Sauer L, Vitale AS, Modersitzki NK, Fleckenstein M, Bernstein PS (2021). Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases. Transl Vis Sci Technol, 10(7), 11.
  12. da Palma MM, Igelman AD, Ku C, Burr A, You JY, Place EM, Wang NK, Oh JK, Branham KE, Zhang X, Ahn J, Gorin MB, Lam BL, Ronquillo CC, Bernstein PS, Nagiel A, Huckfeldt R, Cabrera MT, Kelly JP, Bakall B, Iannaccone A, Hufnagel RB, Zein WM, Koenekoop RK, Birch DG, Yang P, Fahim AT, Pennesi ME (2021). Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome. Invest Ophthalmol Vis Sci, 62(7), 27.
  13. Addo EK, Gorusupudi A, Allman S, Bernstein PS (2021). The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial. Trials, 22(1), 300.
  14. Gorusupudi A, Rallabandi R, Li B, Arunkumar R, Blount JD, Rognon GT, Chang FY, Wade A, Lucas S, Conboy JC, Rainier JD, Bernstein PS (2021). Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice. Proc Natl Acad Sci U S A, 118(6).
  15. Bernstein PS, Arunkumar R (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J Lipid Res, 62, 100038.
  16. Bernstein PS, Ranganathan A (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J Lipid Res, 100038.
  17. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2020). Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond. Eye (Lond), 35(1), 93-109.
  18. Lakk M, Hoffmann GF, Gorusupudi A, Enyong E, Lin A, Bernstein PS, Toft-Bertelsen T, MacAulay N, Elliott MH, Kriaj D (2021). Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension. J Lipid Res, 62, 100145.
  19. Hicks PM, Haaland B, Feehan M, Crandall AS, Pettey JH, Nuttall E, Self W, Hartnett ME, Bernstein P, Vitale A, Shakoor A, Shulman JP, Sieminski SF, Kim I, Owen LA, Murtaugh MA, Noyes A, DeAngelis MM (2020). Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain West. J Clin Med, 9(11).
  20. Arunkumar R, Gorusupudi A, Bernstein PS (2020). The macular carotenoids: A biochemical overview. Biochim Biophys Acta Mol Cell Biol Lipids, 1865(11), 158617.
  21. Rai BB, Morley MG, Zangmo P, Tshering T, Khatiwara AN, Bernstein PS, Maddess T (2020). Retinal laser services in Bhutan: a 3-year national survey. BMC Ophthalmol, 20(1), 404.
  22. Vitale AS, Sauer L, Modersitzki NK, Bernstein PS (2020). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia. Transl Vis Sci Technol, 9(10), 33.
  23. Rai BB, Morley MG, Zangmo P, Tschering T, Khatiwara AN, Bernstein PS, Maddes T (2020). Surgical Management of VR Patients in Bhutan.
  24. Zucker CL, Bernstein PS, Schalek RL, Lichtman JW, Dowling JE (2020). A connectomics approach to understanding a retinal disease. Proc Natl Acad Sci U S A, 117(31), 18780-18787.
  25. Sauer L, Vitale AS, Milliken CM, Modersitzki NK, Blount JD, Bernstein PS (2020). Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender. Transl Vis Sci Technol, 9(9), 2.
  26. Obana A, Gohto Y, Nakazawa R, Moriyama T, Gellermann W, Bernstein PS (2020). Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels. Sci Rep, 10(1), 10262.
  27. Zhai Y, Xu M, Dimopoulos IS, Birch DG, Bernstein PS, Holt J, Kirn D, Francis P, MacDonald IM (2020). Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Transl Vis Sci Technol, 9(7), 21.
  28. Li B, George EW, Rognon GT, Gorusupudi A, Ranganathan A, Chang FY, Shi L, Frederick JM, Bernstein PS (2020). Imaging lutein and zeaxanthin in the human retina with confocal resonance Raman microscopy. Proc Natl Acad Sci U S A, 117(22), 12352-12358.
  29. Sauer L, Vitale AS, Andersen KM, Hart B, Bernstein PS (2019). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina, 40(4), 695-704.
  30. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS (2020). Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals. Jpn J Ophthalmol, 64(2), 160-170.
  31. Rai BB, Morley MG, Bernstein PS, Maddess T (2020). Pattern of vitreo-retinal diseases at the national referral hospital in Bhutan: a retrospective, hospital-based study. BMC Ophthalmol, 20(1), 51.
  32. Green-Gomez M, Bernstein PS, Curcio CA, Moran R, Roche W, Nolan JM (2019). Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique. Transl Vis Sci Technol, 8(6), 41.
  33. Bernstein PS (2019). Does Dark Chocolate Enhance Visual Function? JAMA Ophthalmol, 137(12), 1380.
  34. Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander M (2019). Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. N Engl J Med, 381(15), 1422-1433.
  35. Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein PS (2019). Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy. Ophthalmol Retina, 3(10), 814-825.
  36. Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Sahel JA, Sunness JS, Traboulsi EI, Zrenner E, Pitetta S, Jenkins D, Hariri AH, Sadda S, Scholl HPN, ProgStar Study Group (2019). Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. JAMA Ophthalmol, 137(10), 1134-1145.
  37. Ronquillo CC, Sauer L, Morgan D, Heckzo JB, Creel DJ, Mamalis N, DeAngelis MM, Hagemann GS, Bernstein PS (2019). ABSENCE OF MACULAR DEGENERATION IN A PATIENT WITH ACERULOPLASMINEMIA. Retina, 39(9), 1824-1828.
  38. Sauer L, Li B, Bernstein PS (2019). Ocular Carotenoid Status in Health and Disease. Annu Rev Nutr, 39, 95-120.
  39. Gorusupudi A, Chang FY, Nelson K, Hageman GS, Bernstein PS (2019). n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models. Mol Nutr Food Res, 63(15), e1801058.
  40. Sauer L, Komanski CB, Vitale AS, Hansen ED, Bernstein PS (2019). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 60(8), 3054-3063.
  41. Obana A, Gohto Y, Gellermann W, Ermakov IV, Sasano H, Seto T, Bernstein PS (2019). Skin Carotenoid Index in a large Japanese population sample. Sci Rep, 9(1), 9318.
  42. Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN, ProgStar Study Group, ProgStar Study Group (2018). Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br J Ophthalmol, 103(3), 390-397.
  43. Hicks PM, Melendez SAC, Vitale A, Self W, Hartnett ME, Bernstein P, Morgan DJ, Feehan M, Shakoor A, Kim I, Owen LA, DeAngelis MM (2019). Genetic Epidemiologic Analysis of Hypertensive Retinopathy in an Underrepresented and Rare Federally Recognized Native American Population of the Intermountain West. J Community Med Public Health, 3(1).
  44. Trujillo Tanner C, Caserta MS, Kleinschmidt JJ, Clayton MS, Bernstein PS, Guo JW (2018). Conducting Research With Older Adults With Vision Impairment: Lessons Learned and Recommended Best Practices. Gerontol Geriatr Med, 4, 2333721418812624.
  45. Ronquillo CC, Wegner K, Calvo CM, Bernstein PS (2018). Genetic Penetrance of Macular Telangiectasia Type 2. JAMA Ophthalmol, 136(10), 1158-1163.
  46. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer M (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. J Biomed Opt, 23(9), 1-20.
  47. Cheng JL, Farnsworth K, Bernstein PS (2018). Choroideremia in a Woman With Turner Syndrome. JAMA Ophthalmol, 136(9), 1076-1078.
  48. Li B, Rognon GT, Mattinson T, Vachali PP, Gorusupudi A, Chang FY, Ranganathan A, Nelson K, George EW, Frederick JM, Bernstein PS (2018). Supplementation with macular carotenoids improves visual performance of transgenic mice. Arch Biochem Biophys, 649, 22-28.
  49. Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein PS (2018). Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol, 7(3), 20.
  50. Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein PS (2018). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment. Invest Ophthalmol Vis Sci, 59(7), 3094-3103.
  51. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS (2018). Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging. Invest Ophthalmol Vis Sci, 59(7), 3011-3019.
  52. Arunkumar R, Calvo CM, Conrady CD, Bernstein PS (2018). What do we know about the macular pigment in AMD: the past, the present, and the future. Eye (Lond), 32(5), 992-1004.
  53. Bhosale P, Zhao DY, Bernstein PS (2007). HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci, 48(2), 543-9.
  54. Bhosale P, Bernstein PS (2005). Microbial xanthophylls. Appl Microbiol Biotechnol, 68(4), 445-55.
  55. Bernstein PS, Gellermann W (2002). Measurement of carotenoids in the living primate eye using resonance Raman spectroscopy. Methods Mol Biol, 196, 321-9.

Editorial

  1. Bernstein PS, Sauer L (2019). Fluorescence Lifetime Imaging Ophthalmoscopy: A New Era of Autofluorescence Imaging of the Human Retina. Retina, 39(5), 817-819.

Letter

  1. Simonett JM, Shakoor A, Bernstein PS (2020). Intentional retinal injury with handheld lasers is an underrecognized form of self-harm. [Letter to the editor]. J Affect Disord, 281, 503-504.

Other

  1. Kuppermann BD, Bernstein P, Mones J, Do DV, Neumann R, Rosenfeld PJ (2019). ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases. J Ocul Pharmacol Ther (35(8), pp. 424-432). United States.

Patent

  1. Gellermann W, McClane RW, Bernstein PS (2007). Optical method and apparatus for determining status of agricultural products. U.S. Patent No. 10.271.914. Washington, D.C.:U.S. Patent and Trademark Office.
  2. McClane RW, Gellermann W, Bernstein PS (2006). Method and apparatus for Raman imaging of macular pigments. U.S. Patent No. 7.039.452. Washington, D.C.:U.S. Patent and Trademark Office.
  3. Gellermann W, McClane RW, Katz NB, Bernstein PS (2001). Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue. U.S. Patent No. 6,205,354. Washington, D.C.:U.S. Patent and Trademark Office.
  4. Bernstein PS, Gellermann W, McClane RW (1999). Method and system for measurement of macular carotenoid levels. U.S. Patent No. 5,873,831. Washington, D.C.:U.S. Patent and Trademark Office.

Global Impact

Selected Provider Publications

Journal Article

  1. Hicks PM, Haaland B, Feehan M, Crandall AS, Pettey JH, Nuttall E, Self W, Hartnett ME, Bernstein P, Vitale A, Shakoor A, Shulman JP, Sieminski SF, Kim I, Owen LA, Murtaugh MA, Noyes A, DeAngelis MM (2020). Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain West. J Clin Med, 9(11).
    Global Impact: Native American Nations.

  2. Rai BB, Morley MG, Zangmo P, Tshering T, Khatiwara AN, Bernstein PS, Maddess T (2020). Retinal laser services in Bhutan: a 3-year national survey. BMC Ophthalmol, 20(1), 404.
    Global Impact: Bhutan.

  3. Rai BB, Morley MG, Zangmo P, Tschering T, Khatiwara AN, Bernstein PS, Maddes T (2020). Surgical Management of VR Patients in Bhutan.
    Global Impact: Bhutan.

  4. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS (2020). Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals. Jpn J Ophthalmol, 64(2), 160-170.
    Global Impact: Japan.

  5. Rai BB, Morley MG, Bernstein PS, Maddess T (2020). Pattern of vitreo-retinal diseases at the national referral hospital in Bhutan: a retrospective, hospital-based study. BMC Ophthalmol, 20(1), 51.
    Global Impact: Bhutan.

News Articles

Breakthrough by Moran Eye Center Scientist, Colleagues Fuels New Line of Disease Research

Detecting Eye Diseases Earlier Than Ever With FLIO

Moran Patients, Physicians, Staff Navigating Care for Vision-Threatening Conditions During the Covid-19 Pandemic 

The Future of Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Clinical Care

Carrots & Eye Health: Myth or Fact?

Moran’s Paul S. Bernstein, MD, PhD, Receives ARVO’s Mildred Weisenfeld Award

John A. Moran Eye Center Researcher, Patients, Play Key Role in Genetic Discovery Linked to Rare Eye Disease

John A. Moran Eye Center Researcher, Patients, Play Key Role in Genetic Discovery Linked to Rare Eye Disease

Moran Eye Center Celebrates Achievements of Donors and Faculty Holding Endowed Chairs and Professorships

Moran Eye Center’s Paul Bernstein and Mary Elizabeth Hartnett to Receive Prestigious Macula Society Awards

Technology and Innovation Showcased at Moran Eye Center’s Translational Research Day

Moran Eye Center Physicians Paul Bernstein and Mary Elizabeth Hartnett Appointed to University of Utah Endowed Chairs

Moran Researchers Tracking Down Disease Earlier with FLIO

Keep an Eye on Diabetes

Moran Eye Center’s Binxing Li Awarded $160,000 BrightFocus Grant

Moran Researchers Garner Support of Knights Templar

Making Their Mark: Moran Docs Recognized By ARVO, ASCRS

Is More Better? Finding the Balance Between Nutritional Supplements and Eye Health

Green Is Great When Trying To Eat Eye-healthy Foods, But Is More, Better?

Moran at AAO 2016: Awards, Presentations, & Contributions

Eye on Diabetes

Dr. Paul Bernstein Wins Utah Humanitarian Award

Moran Researcher Helps to Discover New Risks for Age-Related Macular Degeneration

Researcher Helps to Discover New Risks for Age-Related Macular Degeneration

Nutrition & Macular Degeneration

Researchers: Omega-3 fatty acids don't reduce the risk of macular degeneration

The Scope & Other Podcasts

  • Meet Paul S. Bernstein, MD, PhD
  • “New Frontiers in the Treatment of Macular and Retinal Disease: Nutrition, Stem Cells, Gene Therapy, and Beyond.”
  • Update on Aging Macular Degeneration Treatments, Research
  • What You Need to Know About Aging Macular Degeneration
  • AREDS II Study Overview and Results on AMD Nutrition
  • An Unexpected Pit Stop: teen eye injury

Videos

An Unexpected Pit Stop: teen eye injury

AREDS II Study Overview and Results on AMD Nutrition

“New Frontiers in the Treatment of Macular and Retinal Disease: Nutrition, Stem Cells, Gene Therapy, and Beyond.”

Meet Paul S. Bernstein, MD, PhD

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health